I have read many books on the changing tide of the public's relationship with vaccines, particularly around childhood ...

Anti-vaccine activists seized on a deadly outbreak in Seminole, setting off a battle between fringe doctors and mainstream ...

From unraveling the mysteries of the cosmos to revolutionizing medicine, the 21st century has been a golden age of scientific discovery. Join us as we explore the groundbreaking advancements that have ...

After spending five years piecing the story together, Herder said Canada's Ebola vaccine experience challenges the dogma ... he designed an experiment trying to identify the key protein that made ...

Many people contributed to the development of Merck’s Ebola vaccine ... But here are some of the people who made key contributions to the development of a vaccine that seemed for years like ...

On Thursday, the FDA announced the approval of the Ebola vaccine ... In addition, the vaccine was tested in Liberia, Sierra Leone, Canada, Spain and the U.S., with similar results.

The announcement, made Thursday, comes a month after the European Union and the World Health Organization, the global health arm of the United Nations, both approved the Ebola vaccine. Ebola cases ...

As the Ebola outbreak in ... The first vaccine, a single-dose live concoction called Ervebo, has been in testing since 2014. It was developed in Canada and eventually licensed by Merck & Co ...

It wasn’t as if pharmaceutical companies were lining up to further develop the vaccine. Everything changed in 2014 when the West Africa Ebola outbreak made international news. Suddenly ...

The vaccine, which protects against the Zaire species of Ebola, was designed at Canada’s National Microbiology ... nor any other Ebola vaccine would be made, because there isn’t a traditional ...

The vaccine, which protects against the Zaire species of Ebola, was designed at Canada’s National Microbiology ... nor any other Ebola vaccine would be made, because there isn’t a traditional ...

The Ebola vaccine was originally developed in Canada and is now marketed by Merck ... A second vaccine made by Johnson & Johnson, which is not yet licensed, will soon be used in parts of Congo ...